# Differential Myocardial Responses in Male and Female Rats with Uremic Cardiomyopathy

**Authors:** Beáta Bódi, Rebeka Rita Vágó, László Nagy, Arnold Péter Ráduly, András Gulyás, Klaudia Kupecz, Lilian Azar, Fanni Magdolna Márványkövi, Gergő Szűcs, Andrea Siska, Gábor Cserni, Imre Földesi, Zoltán Papp, Márta Sárközy

PMC · DOI: 10.3390/ijms26052259 · International Journal of Molecular Sciences · 2025-03-03

## TL;DR

This study shows that male rats develop more severe heart complications from kidney disease compared to female rats, highlighting a sex-based difference in uremic cardiomyopathy.

## Contribution

The study reveals sex-specific differences in the severity of uremic cardiomyopathy in a rat model, emphasizing male susceptibility.

## Key findings

- Male rats showed greater left ventricular hypertrophy, diastolic dysfunction, and fibrosis compared to females.
- Male rats had reduced maximal Ca2+-activated force and increased passive stiffness in cardiomyocytes.
- Lower cMyBP-C phosphorylation levels were observed in male rats compared to females.

## Abstract

Uremic cardiomyopathy, characterized by diastolic dysfunction, left ventricular hypertrophy (LVH), and fibrosis, is a common cardiovascular complication of chronic kidney disease (CKD). Men are at a higher risk for cardiovascular and renal diseases, compared to age-matched, pre-menopausal women. We aimed to investigate the influence of sex on the severity of uremic cardiomyopathy through the characterization of functional and molecular indices of myocardial remodeling in a rat model. CKD was induced by a 5/6 nephrectomy in 9-week-old male and female Wistar rats. Serum and urine tests, transthoracic echocardiography, left ventricular (LV) histology, and quantitative reverse transcription polymerase chain reaction (RT-qPCR) were performed at week 8 or 9. Moreover, LV alterations were also tested in permeabilized cardiomyocytes (CMs) by force measurements and Western immunoblotting. CKD resulted in the development of a more severe uremic cardiomyopathy in male rats—including LVH, LV diastolic dysfunction, and fibrosis—than in female rats, where only LVH was observed. A uremic cardiomyopathy was also associated with a decrease in maximal Ca2+-activated force (Fmax) in CMs of male rats. Additionally, increases in CM Ca2+-independent passive stiffness (Fpassive) and decreases in cardiac myosin-binding protein C (cMyBP-C) phosphorylation levels were significantly larger in male than female rats. In conclusion, a uremic cardiomyopathy involved cardiac remodeling in both sexes. Nevertheless, male rats exhibited more pronounced signs of macroscopic and microscopic alterations than their female counterparts, illustrating a sex-dependent component of uremic cardiomyopathy.

## Linked entities

- **Proteins:** MYBPC3 (myosin binding protein C3)
- **Diseases:** chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Diseases:** LVH (MESH:D017379), Uremic Cardiomyopathy (MESH:D009202), fibrosis (MESH:D005355), cardiac remodeling (MESH:D020257), myocardial remodeling (MESH:D064752), LV diastolic dysfunction (MESH:D018487), cardiovascular and renal diseases (MESH:D002318), CKD (MESH:D051436)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11900185/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11900185/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC11900185/full.md

---
Source: https://tomesphere.com/paper/PMC11900185